The impact of white matter hyperintensities on short-term outcomes of reperfusion therapy in patients with acute ischemic stroke

This study aimed to explore the impact of white matter hyperintensities (WMH) on the short-term outcomes of reperfusion therapy in acute ischemic stroke (AIS) patients.

We prospectively collected data on AIS patients undergoing reperfusion therapies at Chengdu Second People’s Hospital from January 2020 and January 2024. WMH severity was graded as 0–3 (none to moderate) or 4–6 (severe) by the Fazekas scale. We analyzed National Institutes of Health Stroke Scale (NIHSS) scores, good functional outcomes (modified Rankin Scale, mRS 0–2) at 7 days and discharge, and safety outcomes like in-hospital mortality and intracranial hemorrhage.

During the study period, 669 patients were included, with 345 having none to moderate WMH and 324 with severe WMH. Patients with severe WMH exhibited significantly higher NIHSS and mRS at 7 days and discharge, with a decrease in good outcomes (mRS 0–2: 40.43% vs. 75.65%), and an increase in intracranial hemorrhage (16.4% vs. 5.8%) and in-hospital mortality (11.7% vs. 2.0%) compared with none to moderate WMH patients. After matching the baseline data, none to moderate WMH was associated with higher likelihood of good outcomes at discharge [adjusted odds ratio (aOR), 2.142; 95% confidence interval (CI), 1.380–3.304; P < 0.001] and a lower rate of any intracranial hemorrhage (aOR, 0.348; 95% CI 0.180–0.673; P < 0.001), with no significant difference in in-hospital mortality between the groups.

Severe WMH could reduce the benefits of reperfusion therapy in AIS, with increased risk of hemorrhagic complications, warranting further research into treatment strategies for these patients.